TRPV3

Chr 17AD

transient receptor potential cation channel subfamily V member 3

Also known as: FNEPPK2, OLMS, OLMS1, VRL3

TRPV3 encodes a temperature-sensitive calcium-permeable cation channel that is activated by warm temperatures (22-40°C) and regulates keratinocyte proliferation and hair follicle cycling. Mutations cause autosomal dominant Olmsted syndrome and focal nonepidermolytic palmoplantar keratoderma, both affecting skin and hair development. The gene shows low constraint against loss-of-function variants, suggesting the pathogenic variants may work through other mechanisms.

OMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismADLOEUF 1.152 OMIM phenotypes
Clinical SummaryTRPV3
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
26 unique Pathogenic / Likely Pathogenic· 212 VUS of 400 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.15LOEUF
pLI 0.000
Z-score 0.82
OE 0.86 (0.651.15)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.17Z-score
OE missense 0.98 (0.911.06)
467 obs / 477.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.86 (0.651.15)
00.351.4
Missense OE0.98 (0.911.06)
00.61.4
Synonymous OE1.03
01.21.6
LoF obs/exp: 33 / 38.5Missense obs/exp: 467 / 477.5Syn Z: -0.31
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedTRPV3-related palmoplantar keratoderma, nonepidermolytic, focalOTHERAD
strongTRPV3-related Olmsted syndromeOTHERAD
DN
0.6259th %ile
GOF
0.77top 25%
LOF
0.3454th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median · 1 literature citation
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

GOFMutations in TRPV3 (Transient receptor potential vanilloid-3) gene have recently been identified as a cause of autosomal dominant (gain-of-function mutations) or recessive OS.PMID:25886873

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

400 submitted variants in ClinVar

Classification Summary

Pathogenic24
Likely Pathogenic2
VUS212
Likely Benign58
Benign81
Conflicting16
24
Pathogenic
2
Likely Pathogenic
212
VUS
58
Likely Benign
81
Benign
16
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
4
20
0
24
Likely Pathogenic
0
0
2
0
2
VUS
3
140
68
1
212
Likely Benign
0
10
20
28
58
Benign
1
13
49
18
81
Conflicting
16
Total416715947393

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

TRPV3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 5 results · since 2015Search PubMed ↗